Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Non-Current Assets: 2013-2018

Historic Non-Current Assets for Soleno Therapeutics (SLNO) over the last 6 years, with Dec 2018 value amounting to $18.5 million.

  • Soleno Therapeutics' Non-Current Assets fell 11.87% to $17.1 million in Q3 2019 from the same period last year, while for Sep 2019 it was $17.1 million, marking a year-over-year decrease of 11.87%. This contributed to the annual value of $18.5 million for FY2018, which is 12.11% down from last year.
  • Per Soleno Therapeutics' latest filing, its Non-Current Assets stood at $18.5 million for FY2018, which was down 12.11% from $21.0 million recorded in FY2017.
  • In the past 5 years, Soleno Therapeutics' Non-Current Assets ranged from a high of $21.0 million in FY2017 and a low of $57,607 during FY2014.
  • Its 3-year average for Non-Current Assets is $13.8 million, with a median of $18.5 million in 2018.
  • In the last 5 years, Soleno Therapeutics' Non-Current Assets spiked by 3,019.23% in 2015 and then dropped by 12.11% in 2018.
  • Yearly analysis of 5 years shows Soleno Therapeutics' Non-Current Assets stood at $57,607 in 2014, then spiked by 3,019.23% to $1.8 million in 2015, then fell by 1.86% to $1.8 million in 2016, then soared by 1,092.36% to $21.0 million in 2017, then fell by 12.11% to $18.5 million in 2018.